Telomir Pharmaceuticals (TELO) News Today → He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (From InvestorPlace) (Ad) Free TELO Stock Alerts $6.00 -0.18 (-2.91%) (As of 09:30 AM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14, 2024 | investorplace.comTELO Stock Earnings: Telomir Pharmaceuticals Reported Results for Q1 2024April 22, 2024 | marketbeat.comTrading was temporarily halted for "TELO" at 11:04 AM with a stated reason of "LULD pause."April 16, 2024 | globenewswire.comTelomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C.April 2, 2024 | globenewswire.comTelomir Pharmaceuticals' Anti-Aging Expert and NYT Bestselling Author Michael F. Roizen, MD, to Present Promising Pre-Clinical Data for Age-Reversal Drug Telomir-1 at the National Press Club in Washington, DC, on April 15, 2024March 29, 2024 | globenewswire.comUPDATE – Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in CaninesMarch 26, 2024 | globenewswire.comTelomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in CaninesMarch 22, 2024 | globenewswire.comTelomir Pharmaceuticals Releases New Pre-Clinical Data for Telomir-1 to Be Presented at the Global Longevity Federation Conference in Las Vegas on March 26thMarch 14, 2024 | globenewswire.comTelomir Pharmaceuticals Uses AI Testing Models to Show its Lead Product Candidate's Potential in DNA Age Reversal ScienceMarch 7, 2024 | globenewswire.comTelomir Pharmaceuticals Presents Promising Pre-Clinical Data For Its Lead Development Product at Singapore ConferenceMarch 7, 2024 | globenewswire.comTelomir Pharmaceuticals Presents Promising Pre-Clinical Data For Its Lead Development Product at Singapore ConferenceMarch 5, 2024 | globenewswire.comMichael F. Roizen, MD to Increase Activities with Telomir Pharmaceuticals as Special Advisor on Age ReversalFebruary 20, 2024 | marketbeat.comTrading was temporarily halted for "TELO" at 10:02 AM with a stated reason of "LULD pause."February 14, 2024 | marketbeat.comTrading was temporarily halted for "TELO" at 03:02 PM with a stated reason of "LULD pause."February 14, 2024 | marketbeat.comTrading was temporarily halted for "TELO" at 03:02 PM with a stated reason of "LULD pause."February 14, 2024 | marketbeat.comTrading was temporarily halted for "TELO" at 02:02 PM with a stated reason of "LULD pause."February 14, 2024 | marketbeat.comTrading was temporarily halted for "TELO" at 02:02 PM with a stated reason of "LULD pause."February 14, 2024 | marketbeat.comTrading was temporarily halted for "TELO" at 01:02 PM with a stated reason of "LULD pause."February 12, 2024 | marketbeat.comTrading was temporarily halted for "TELO" at 01:02 PM with a stated reason of "LULD pause." Trading set to resume at 01:02 PM. February 9, 2024 | marketbeat.comTrading was temporarily halted for "TELO" at 11:02 AM with a stated reason of "LULD pause."February 9, 2024 | marketbeat.comTrading was temporarily halted for "TELO" at 11:02 AM with a stated reason of "LULD pause."February 9, 2024 | marketbeat.comTrading was temporarily halted for "TELO" at 10:02 AM with a stated reason of "LULD pause." Get Telomir Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TELO and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden Nomination CANCELED? (Ad)The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words? I believe I have the terrifying answer right here. TELO Media Mentions By Week TELO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TELO News Sentiment▼0.820.42▲Average Medical News Sentiment TELO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TELO Articles This Week▼31▲TELO Articles Average Week Get Telomir Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TELO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Prelude Therapeutics News Greenwich LifeSciences News Capricor Therapeutics News Incannex Healthcare News Lifecore Biomedical News Inventiva News Omeros News scPharmaceuticals News Rigel Pharmaceuticals News Acrivon Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TELO) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldShocking: One AI startup's revenue could surge 4,735%Manward PressDoes this make you sick?Allegiance GoldCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingBiden Nomination CANCELED?The Freeport SocietyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telomir Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
